Literature DB >> 8484130

Candida arthritis in adult patients who are not intravenous drug addicts: report of three cases and review of the literature.

E Cuende1, C Barbadillo, R E-Mazzucchelli, C Isasi, A Trujillo, J L Andréu.   

Abstract

Candida species are an uncommon cause of infectious arthritis, although the frequency has increased during recent years. Three cases of septic arthritis caused by Candida species are reported, and the literature is reviewed. The first patient developed a popliteal cyst infected by Candida albicans after multiple intravenous antibiotic treatments. The second patient had acute myelogenous leukemia and experienced knee arthritis after chemotherapy, and the third suffered oligoarthritis after a second heart transplantation. All patients received treatment with a standard dose of intravenous amphotericin B. Responses were achieved only in the first two cases; the third patient died despite therapy. Thirty-six previously reported Candida arthritis cases are reviewed, and epidemiologic, diagnostic, therapeutic, and prognostic features are analyzed. Cases are divided into two categories: direct inoculation of fungus and hematogenously disseminated disease; these two categories are compared in terms of sex, age, pathogen species, treatment, and survival. Arthritis induced through direct inoculation of fungus is seen in older individuals, is more frequently produced by species other than C albicans (Candida parapsilosis especially), and has a better prognosis than arthritis caused by disseminated candidiasis. Arthritis can be resolved even in the persistence of the systemic disease. It is believed that the first case of Baker's cyst infected by C albicans and the first case of Candida arthritis in a heart transplant patient are reported here.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8484130     DOI: 10.1016/0049-0172(93)80071-m

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  8 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 2.  Candida tropicalis arthritis in a patient with acute myeloid leukemia successfully treated with fluconazole: case report and review of the literature.

Authors:  G Weers-Pothoff; J F Havermans; J Kamphuis; H A Sinnige; J F Meis
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

3.  An unusual case of Candida tropicalis and Candida krusei arthritis in a patient with acute myelogenous leukemia before chemotherapy.

Authors:  Hon-Pin Wang; Yung-Feng Yen; Wei-Sheng Chen; Yuh-Lan Chou; Chang-Youh Tsai; Hsiao-Ning Chang; Chung-Tei Chou
Journal:  Clin Rheumatol       Date:  2006-06-08       Impact factor: 2.980

Review 4.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 5.  Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option?

Authors:  Theodoros Kelesidis; Sotirios Tsiodras
Journal:  Scand J Infect Dis       Date:  2010

6.  Candida Arthritis after Arthroscopic Arthroplasty in a Patient without Predisposing Factors.

Authors:  Chang-Hun Lee; Jae-Min Oh; Seong-Rheol Oh; Minwook Yoo; Myeung-Su Lee
Journal:  Open Rheumatol J       Date:  2010-02-11

7.  Candida arthritis in an immunocompetent patient without predisposing factors.

Authors:  J M Calvo Romero; J L Alvarez Vega; J M Salazar Vallinas; R Ortega Alberdi
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

8.  Candida Arthritis: Analysis of 112 Pediatric and Adult Cases.

Authors:  Maria N Gamaletsou; Blandine Rammaert; Marimelle A Bueno; Nikolaos V Sipsas; Brad Moriyama; Dimitrios P Kontoyiannis; Emmanuel Roilides; Valerie Zeller; Saad J Taj-Aldeen; Andy O Miller; Ruta Petraitiene; Olivier Lortholary; Thomas J Walsh
Journal:  Open Forum Infect Dis       Date:  2015-12-23       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.